Preliminary Study on Microplastics Deposition in Ventilator Circuit and the Risk of Bronchopulmonary Dysplasia in Premature Infants (Microplastics)
In this study, the premature infants with gestational age less than 30 weeks were taken as the object, and the deposition characteristics of microplastics in ventilator circuit and its correlation with the risk of bronchopulmonary dysplasia were systematically discussed through prospective observation design. The research is divided into two parts: firstly, the release and deposition of microplastics in the ventilator circuit (water storage tank and simulated lung) are detected; Secondly, the changes of microplastics load in airway secretions of children with bronchopulmonary dysplasia on the 0-7th day, 14th day and 28th day were dynamically monitored, and samples of bottle milk and newborn blood were collected simultaneously to evaluate the exposure level of multi-channel microplastics. Microplastics was qualitatively and quantitatively analyzed by confocal micro-Raman spectroscopy, and the dose-response relationship between microplastics load and bronchopulmonary dysplasia was analyzed in combination with clinical data, so as to provide scientific basis for risk prevention and control of iatrogenic microplastics exposure in neonatal intensive care unit. In this study, the blood sample only used the remaining venous blood collected by routine clinical diagnosis and treatment (such as blood routine and blood gas analysis) on the 7th, 14th and 28th day (2 days) after the newborn was admitted to the hospital, and the dosage was 0.5-1 mL, which was placed in a glass anticoagulant tube. Each child is collected at most once. If there is no clinical blood collection at this time point, no additional puncture blood collection will be carried out to ensure that the operating burden and risk of children will not be increased.
연구 개요
상태
상태
정황
정황
상세 설명
Objective To investigate the relationship between microplastics deposition in ventilator circuit and bronchopulmonary dysplasia (BPD) in premature infants, and to evaluate the risk of iatrogenic microplastics exposure in NICU.
Methods A prospective observational cohort study was conducted. Premature infants with gestational age less than 30 weeks who needed mechanical ventilation were divided into groups according to whether BPD occurred or not. Samples of condensate water, simulated lung lavage fluid, airway secretions, blood and milk were collected, and microplastics characteristics were detected by acid digestion, vacuum filtration and confocal micro Raman spectrometer. Clinical data were collected and analyzed by multivariate statistics.
Hypothesis: It is expected that microplastics such as polyethylene and polypropylene can be detected in the ventilator circuit. Microplastics load of airway secretion in BPD group increased significantly, which was positively correlated with ventilation duration and showed an increasing trend with the course of disease. Inhalation is the main exposure route, and airway microplastics load may be an independent risk factor for BPD.
This study provides a basis for the safety assessment and clinical prevention and control of medical equipment and materials in NICU.
연구 유형
연구 유형
등록 (추정된)
등록
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Neonates with invasive mechanical ventilation
설명
Inclusion criteria:Neonates with invasive mechanical ventilation Exclusion criteria:1、Children who died of genetic metabolism and congenital heart disease 2、Family members refused to carry out the experiment.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: CASE_CONTROL
- 시간 관점: PROSPECTIVE
그룹/코호트 수
코호트 및 개입
그룹/코호트그룹/코호트 |
|---|
|
BPD group
|
|
Non-BPD group
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Microplastics deposition of airway secretions.
기간: up to 4 weeks
|
Measure the average particle size, quantity and type of microplastics. |
up to 4 weeks
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Incidence of bronchopulmonary dysplasia
기간: 1 month
|
incidence rate |
1 month
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- 2026-KY-KZ-146-02
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .